抄録
Purpose: To present a review of stroke and myocardial infarction following intravitreal anti-VEGF treatment. Cases and Method: This retrospective study was made on 960 patients who received intravitreal injection of anti-VEGF during the past 6 years at Toyama University Hospital. The series comprised 593 males and 367 females. The age averaged 70.9 years at the start of treatment. Results: Cerebral stroke developed in 11 cases (l.2%) and myocardial infarction developed in 3 cases (0.3%). Stroke of myocardial infarction developed in 5 cases within one month of vitreal injection of aflibercept as anti-VEGF. Conclusion: Stroke or myocardial infarction developed in 1.4% of cases receiving intravitreal anti-VEGF. Aflibercept appeared to be followed by cerebral or myocardial accidents within one month of treatment.
| 本文言語 | 英語 |
|---|---|
| ページ（範囲） | 551-557 |
| ページ数 | 7 |
| ジャーナル | Japanese Journal of Clinical Ophthalmology |
| 巻 | 71 |
| 号 | 4 |
| 出版ステータス | 出版済み - 2017/04 |
ASJC Scopus 主題領域
- 眼科学